IOVANCE BIOTHERAPEUTICS INC COM USD0.000041666 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0JDK for the last quarter is 31.11 M USD, and it's 4250.49% higher compared to the previous quarter. The net income of Q2 24 is -97.10 M USD.